DFS
64
2
SEE
56
6
AN
58
4
SCHW
62
-2
PSX
47
2
MET
72
5
MHK
49
4
CRM
67
2
CFG
70
6
KEY
46
3
ORLY
62
2
WM
79
3
RL
72
4
GT
62
6
ADT
53
3
HSIC
56
5
IR
66
3
CSX
60
3
INTC
33
-2
PEP
48
6
DFS
64
2
SEE
56
6
AN
58
4
SCHW
62
-2
PSX
47
2
MET
72
5
MHK
49
4
CRM
67
2
CFG
70
6
KEY
46
3
ORLY
62
2
WM
79
3
RL
72
4
GT
62
6
ADT
53
3
HSIC
56
5
IR
66
3
CSX
60
3
INTC
33
-2
PEP
48
6
Financhill
Back

Evaxion Biotech AS Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
5

EVAX
Evaxion Biotech AS

Last Price:
1.42
Seasonality Move:
-40.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Evaxion Biotech AS Price Quote

$1.42
-0.07 (3.65%)
(Updated: November 23, 2024 at 5:34 AM ET)

Evaxion Biotech AS Key Stats

Sell
5
Evaxion Biotech AS (EVAX) is a Sell
Day range:
$1.36 - $1.49
52-week range:
$1.28 - $13.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.06
P/B ratio:
118.11%
Volume:
13K
Avg. volume:
32K
1-year change:
-81.38%
Market cap:
$8.7M
Revenue:
$73K
EPS:
$-2.8

How Much Does Evaxion Biotech AS Make?

Is Evaxion Biotech AS Growing As A Company?

Data Unavailable

Evaxion Biotech AS Stock Price Performance

What Is Evaxion Biotech AS 52-Week High & Low?

Evaxion Biotech AS Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Evaxion Biotech AS?

Is Evaxion Biotech AS Cash Flow Positive?

Data Unavailable

Evaxion Biotech AS Return On Invested Capital

  • Is Management Doing A Good Job?
    EVAX return on invested capital is -238.97%
  • What Is Evaxion Biotech AS Return On Assets?
    ROA measures how assets are converting to revenues and is -69.51%
  • What Is EVAX Return On Equity?
    ROE is a measure of profitability and is 0%

Evaxion Biotech AS Earnings Date & Stock Price

Evaxion Biotech AS Competitors

  • Who Are Evaxion Biotech AS's Competitors?
    Below is a list of companies who compete with Evaxion Biotech AS or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Akari Therapeutics PLC (AKTX)
    • Ascendis Pharma AS (ASND)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • DBV Technologies SA (DBVT)

Evaxion Biotech AS Dividend Yield

Evaxion Biotech AS Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 66.67%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.56
Upside from Last Price: 676.01%

Major Shareholders

  • How many EVAX shares are owned by institutional investors?
    562.5K EVAX shares are owned by institutional investors
  • How many EVAX shares are owned by insiders?
    0 EVAX shares are owned by insiders